Abbvie Inc (ABBV US)

187

Analysis

Health Care • United States

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Refresh

Company Presentation • 22 Jun 2026 21:00

M&A announcement

Company Presentation • 02 Feb 2024 20:00

AbbVie Long-Term Guidance and Pipeline Update Presentation

Company Presentation • 31 Jan 2025 20:00

AbbVie Pipeline Update Presentation

Company Presentation • 05 Mar 2015 22:00

M&A Announcement

Company Presentation • 02 Feb 2024 22:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

M&A announcement

AbbVie Long-Term Guidance and Pipeline Update Presentation

AbbVie Pipeline Update Presentation

M&A Announcement

Q4 2023